The Dexa-C system uses Aurora Spine’s patented color-coded implants which come in varyinh densities to match a patient’s bone density, according to a news release. The device is designed for anterior cervical discectomy and fusions.
Aurora Spine’s study will span up to 10 sites and enroll at least 40 single-level and 40-multi-level patients. Outcomes are expected to be measured at three months, six months and 12 months post-surgery.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
